555-555-5555|liferaft@liferaftgroup.org
FacebookLinkedInTwitterYouTubeInstagram

Harvard

Accelerating Innovation in Precision Medicine

Sara Rothschild, VP Programs and Services at the LRG, attended an executive education program at the Harvard Business School which brought together leaders from the health care, scientific, technological, and business communities to speed progress and drive cures.

By |2019-12-19T11:25:32-05:00November 3rd, 2019|News, Survival Strategies|
Read More

LRG Research Team members publish results of imatinib combination study

Drs. Jonathan Fletcher, of Brigham & Women’s Hospital, Harvard University and Maria Debiec-Rychter, of the Catholic University in Leuven, Belgium, members of the LRG Research Team were part of a recently published study that looked at the effectiveness of GDC-0941, a PI3K inhibitor when used in combination with imatinib (Gleevec).

By |2019-09-20T13:20:42-04:00February 1st, 2013|News, Research|
Read More

The Life Raft Group
155 US Highway 46, Suite 202
Wayne, NJ 07470 USA

Phone 973-837-9092
Contact us by email

The Life Raft Group is a 501 (c)(3) non-profit organization (tax id: 82-0547746) providing support through information, education, and innovative research to patients with a rare cancer called GIST (Gastrointestinal Stromal Tumor). View our 990 Form here

The information provided on the LRG site is designed to support, not to replace, the relationship that exists between a patient/site visitor and his/her physician. Read our Privacy Policy

 

Silver GuideStar - Seal of Transparency

The LRG website is dedicated in perpetuity to the memory of Mary S. Golnik.

Toggle Sliding Bar Area
Go to Top